» Articles » PMID: 39394444

Maternal Adiposity and Perinatal and Offspring Outcomes: an Umbrella Review

Overview
Journal Nat Hum Behav
Date 2024 Oct 11
PMID 39394444
Authors
Affiliations
Soon will be listed here.
Abstract

Maternal adiposity deleteriously affects obstetrical health and has been associated with long-term adverse consequences in offspring. Here we conducted an umbrella review encompassing 194 observational meta-analyses, 10 Mendelian randomization studies and 748 interventional meta-analyses to appraise the published evidence on the associations between maternal adiposity and perinatal and offspring outcomes. Evidence grading suggested that 17 (8.8%) observational meta-analyses were supported by convincing evidence for 12 outcomes: maternal adiposity was associated with an increased risk of caesarean delivery following labour induction, infant mortality, Apgar score <7 at 1 min, antenatal depression, offspring overweight and obesity, early timing of puberty onset in daughters, attention deficit hyperactivity disorder, cerebral palsy, congenital heart disease and spina bifida (OR/RR ranging from 1.14 to 2.31), as well as increased offspring body fat percent and fat mass (SMD 0.31 and 0.35, respectively). Among these outcomes, interventional meta-analyses supported that maternal weight loss interventions significantly reduced the risk of antenatal depression but not low Apgar scores; these interventions also could not reduce offspring fat mass or body fat percent. Evidence from Mendelian randomization studies supported a causal relationship between maternal adiposity and gestational diabetes mellitus, preeclampsia, birth size and offspring adiposity. Our findings highlight that while observational meta-analyses reveal associations between maternal adiposity and various adverse perinatal and offspring outcomes, convincing, unbiased evidence or support from Mendelian randomization studies is limited. Maternal pre-conceptional and prenatal weight loss interventions can reduce some, but not all, of these adverse effects.

Citing Articles

Key glycometabolism during oocyte maturation and early embryonic development.

Zhang Y, Li T, Wang Y, Yu Y Reproduction. 2025; 169(3).

PMID: 39846956 PMC: 11840835. DOI: 10.1530/REP-24-0275.

References
1.
Flegal K, Kruszon-Moran D, Carroll M, Fryar C, Ogden C . Trends in Obesity Among Adults in the United States, 2005 to 2014. JAMA. 2016; 315(21):2284-91. PMC: 11197437. DOI: 10.1001/jama.2016.6458. View

2.
Creanga A, Catalano P, Bateman B . Obesity in Pregnancy. N Engl J Med. 2022; 387(3):248-259. DOI: 10.1056/NEJMra1801040. View

3.
Poston L, Caleyachetty R, Cnattingius S, Corvalan C, Uauy R, Herring S . Preconceptional and maternal obesity: epidemiology and health consequences. Lancet Diabetes Endocrinol. 2016; 4(12):1025-1036. DOI: 10.1016/S2213-8587(16)30217-0. View

4.
Kurz C, Konig A . The causal influence of maternal obesity on preterm birth. Lancet Diabetes Endocrinol. 2019; 8(2):101-103. DOI: 10.1016/S2213-8587(19)30406-1. View

5.
Flenady V, Koopmans L, Middleton P, Froen J, Smith G, Gibbons K . Major risk factors for stillbirth in high-income countries: a systematic review and meta-analysis. Lancet. 2011; 377(9774):1331-40. DOI: 10.1016/S0140-6736(10)62233-7. View